首页> 美国卫生研究院文献>British Journal of Cancer >Prognostic factors in recurrent breast cancer: relationships to site of recurrence disease-free interval female sex steroid receptors ploidy and histological malignancy grading.
【2h】

Prognostic factors in recurrent breast cancer: relationships to site of recurrence disease-free interval female sex steroid receptors ploidy and histological malignancy grading.

机译:复发性乳腺癌的预后因素:与复发部位无病间隔女性类固醇受体倍性和组织学恶性等级的关系。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Site of first recurrence, disease-free interval (DFI), female sex steroid receptors, ploidy measurements as well as histological grading have been analysed as potentially valuable predictive factors in 313 cases of recurrent breast cancer. Univariate and multivariate analyses show histological grading, site of recurrence and disease free interval to be useful prognostic variables when assessing prognosis once disease has recurred. High concentrations of oestrogen receptors (ER) were found in patients with bone metastases, whereas lower concentrations of ER were related to visceral recurrences. Ploidy measurements failed in this study to give any predictive information once disease recurred.
机译:首次复发的部位,无病间隔(DFI),女性类固醇受体,倍性测量以及组织学分级已被分析为313例复发性乳腺癌的潜在有价值的预测因素。单因素和多因素分析表明,一旦疾病复发,在评估预后时,组织学分级,复发部位和无病间隔是有用的预后变量。在骨转移患者中发现高浓度的雌激素受体(ER),而较低的ER与内脏复发有关。疾病复发后,倍性测量未能提供任何预测信息。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号